proceeding
APL_40553/2024 UPC_CoA_405/2024
APL_40553/2024 - Appeal RoP220.1
2024
Luxembourg - Court of Appeal
Date of Filing: 11/07/24
Registry Numbers: APL_40553/2024 UPC_CoA_405/2024
Case Title:
Patents
Patents
TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
Parties
Appellant 1. Alexion Pharmaceuticals, Inc.
Respondent 2. Amgen Technology (Ireland) Unlimited Company
Respondent 3. Amgen N.V.
Respondent 4. Amgen GmbH
Respondent 5. Amgen GmbH
Respondent 6. Amgen AB
Respondent 7. Amgen S.A.S.
Respondent 8. Amgen s.r.l.
Respondent 9. Amgen Biofarmacêutica Lda.
Respondent 10. Amgen Zdravila D.O.O.